Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia
1 clinical trials · Condition
◉ Watch Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia (NCT07604064) | Kissei Pharmaceutical Co., Ltd. | 2026-06-01 |
Track Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.